サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1500816

デジタルPCR市場：世界の産業分析、規模、シェア、成長、動向、予測、2024～2033年

Digital PCR Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

出版日
ページ情報
英文 185 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
デジタルPCR市場：世界の産業分析、規模、シェア、成長、動向、予測、2024～2033年
出版日: 2024年06月20日
発行: Persistence Market Research
ページ情報: 英文 185 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

Persistence Market Researchはこのほど、世界のデジタルPCR市場に関する包括的なレポートを発表しました。この調査レポートは、促進要因・動向・機会・課題を含む重要な市場力学を詳細に評価し、市場構造に関する洞察を提供しています。この調査レポートは、2024年から2033年までのデジタルPCR市場の予測成長軌道を概説する独占データと統計を掲載しています。

主要な洞察

  • 市場規模（2024年）：1億8,380万米ドル
  • 予測市場金額（2033年）：4億380万米ドル
  • 世界市場成長率（CAGR、2024～2033年）：9.1%

デジタルPCR市場 - レポート範囲：

デジタルPCRは、腫瘍学、感染症、遺伝子検査など様々な用途で極めて重要な役割を果たしています。この技術は核酸検出において優れた感度と精度を提供し、研究および臨床診断における正確な定量と分析を可能にします。デジタルPCR市場は、研究室、製薬会社、診断センター、学術機関にサービスを提供し、様々なデジタルPCRプラットフォームと消耗品を提供しています。

市場成長の促進要因：

世界のデジタルPCR市場は、高精度の分子診断に対する需要の増加、慢性疾患の有病率の上昇、アッセイの感度と特異性を高めるデジタルPCR技術の進歩など、いくつかの要因によって促進されています。個別化医療アプローチの採用拡大、リキッドバイオプシーや希少対立遺伝子検出における用途の拡大が市場拡大をさらに後押しします。さらに、分散型検査やポイントオブケア診断へのシフトが市場成長機会を加速します。

市場抑制要因：

有望な成長見通しにもかかわらず、デジタルPCR市場は、高い装置コスト、複雑なアッセイ開発要件、診断検査を管理する規制の複雑さに関連する課題に直面しています。アッセイ性能のばらつきやデータ解析のための熟練者の必要性は、特に資源が限られた環境において、市場浸透のさらなる障壁となります。これらの課題に対処するには、アッセイ設計の継続的な革新、費用対効果の高いプラットフォーム開発、規制経路を合理化するための戦略的提携が必要です。

市場機会：

デジタルPCR市場は、技術革新、ヘルスケア支出の増加、個別化診断ソリューションに対する患者需要の高まりによって大きな成長機会をもたらしています。デジタルPCRプラットフォームにおける人工知能と機械学習の統合は、データ分析能力を強化し、診断精度を向上させます。さらに、非侵襲的出生前検査、感染症モニタリング、がんバイオマーカー分析への応用拡大が市場の展望を広げています。戦略的パートナーシップ、研究開発への投資、新興国市場への地理的拡大は、進化する機会を活用し、競争優位性を維持するために極めて重要です。

本レポートで扱う主要な質問

  • 世界のデジタルPCR市場の成長を促進する主要な要因は何か？
  • デジタルPCR技術の採用を促進している用途とエンドユーザー分野は？
  • 技術の進歩はデジタルPCR市場の競合情勢をどのように変えているのか？
  • デジタルPCR市場に貢献している主要企業はどこで、市場のリーダーシップを維持するためにどのような戦略を採用しているのか？
  • 世界のデジタルPCR市場の新たな動向と将来性は？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲 / 分類
  • 市場の定義 / 範囲 / 制限
  • 包含事項・除外事項

第3章 主要な市場動向

  • 市場に影響を与える主要な動向
  • 製品イノベーション / 開発動向

第4章 主要な成功要因

  • 製品採用分析
  • 新製品の発売と承認
  • 規制シナリオ
  • 主要なプロモーション戦略：メーカー別
  • 最近の製品リリース
  • PESTEL分析
  • ポーターの分析

第5章 市場背景

  • マクロ経済要因
  • 予測要因 - 関連性と影響
  • 市場力学

第6章 COVID19危機分析

  • 2024年の市場シナリオ
  • COVID-19と影響分析
    • 製品別
    • エンドユーザー別
    • 用途別
    • 地域別

第7章 世界のデジタルPCR市場の需要（数量）分析

  • 過去の市場（数量）分析、2019～2023年
  • 現在および将来の市場（数量）予測、2024～2033年
    • 前年比成長動向分析

第8章 世界のデジタルPCR市場 - 価格分析

  • 地域別価格分析：製品別
  • 世界平均価格分析ベンチマーク
  • 価格設定の前提条件

第9章 世界のデジタルPCR市場の需要（金額または規模、百万米ドル）分析

  • 過去の市場金額（百万米ドル）分析、2019～2023年
  • 現在および将来の市場金額（百万米ドル）予測、2024～2033年
    • 前年比成長動向分析
    • 絶対額の機会分析

第10章 世界のデジタルPCR市場分析：製品別

  • イントロダクション / 主要な調査結果
  • 過去の市場規模（百万米ドル）と数量（ユニット）の分析：製品別、2019～2023年
  • 現在および将来の市場規模（百万米ドル）と数量（ユニット）の分析と予測：製品別、2024～2033年
    • 機器
    • 消耗品
    • サービス
  • 市場魅力度分析：製品別

第11章 世界のデジタルPCR市場分析：用途別

  • イントロダクション / 主要な調査結果
  • 過去の市場規模（百万米ドル）分析：用途別、2019～2023年
  • 現在および将来の市場規模（百万米ドル）の分析と予測：用途別、2024～2033年
    • 臨床診断
    • 基礎調査
    • 応用調査
    • 法医学検査
  • 市場魅力度分析：用途別

第12章 世界のデジタルPCR市場分析：エンドユーザー別

  • イントロダクション / 主要な調査結果
  • 過去の市場規模（百万米ドル）分析：エンドユーザー別、2019～2023年
  • 現在および将来の市場規模（百万米ドル）の分析と予測：エンドユーザー別、2024～2033年
    • 製薬会社
    • 調査機関
    • 法医学研究所
    • 農業企業
  • 市場魅力度分析：エンドユーザー別

第13章 世界のデジタルPCR市場分析：地域別

  • イントロダクション
  • 過去の市場規模（百万米ドル）と数量（単位）分析：地域別、2019～2023年
  • 現在および将来の市場規模（百万米ドル）と数量（ユニット）の分析と予測：地域別、2024～2033年
    • 北米
    • ラテンアメリカ
    • 欧州
    • 南アジア
    • 東アジア
    • オセアニア
    • 中東・アフリカ
  • 市場魅力度分析：地域別

第14章 北米のデジタルPCR市場分析

第15章 ラテンアメリカのデジタルPCR市場分析

第16章 欧州のデジタルPCR市場分析

第17章 南アジアのデジタルPCR市場分析

第18章 東アジアのデジタルPCR市場分析

第19章 オセアニアのデジタルPCR市場分析

第20章 中東・アフリカ（MEA）のデジタルPCR市場分析

第21章 市場構造分析

  • 市場分析：企業階層別
  • 主要企業の市場シェア分析
  • 市場プレゼンス分析

第22章 競合分析

  • 競合ダッシュボード
  • 競合ベンチマーク
  • 競合の詳細情報
    • Bio-Rad Laboratories, Inc.
    • Thermo Fisher Scientific Inc.
    • Fluidigm Corp.
    • Formulatrix, Inc.
    • JN Medsys.
    • STILLA TECHNOLOGIES
    • Avance Bioscience
    • Fluidgm corporation,
    • jn medsys
    • Merck KGAA
    • Precigenome LLC
    • QIAGEN NV
    • Sysmex corporation.

第23章 使用される前提条件と頭字語

第24章 調査手法

目次
Product Code: PMRREP20476

Persistence Market Research has recently released a comprehensive report on the global Digital PCR Market. The report offers a detailed assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the digital PCR market from 2024 to 2033.

Key Insights:

  • Market Size (2024E): USD 183.8 Million
  • Projected Market Value (2033F): USD 403.8 Million
  • Global Market Growth Rate (CAGR 2024 to 2033): 9.1%

Digital PCR Market - Report Scope:

Digital PCR plays a pivotal role in various applications, including oncology, infectious diseases, and genetic testing. This technology offers superior sensitivity and accuracy in detecting nucleic acids, enabling precise quantification and analysis in research and clinical diagnostics. The digital PCR market serves research laboratories, pharmaceutical companies, diagnostic centers, and academic institutions, offering a range of digital PCR platforms and consumables.

Market Growth Drivers:

The global digital PCR market is driven by several factors, including increasing demand for high precision molecular diagnostics, rising prevalence of chronic diseases, and advancements in digital PCR technology enhancing assay sensitivity and specificity. Growing adoption of personalized medicine approaches and expanding applications in liquid biopsy and rare allele detection further bolster market expansion. Additionally, the shift towards decentralized testing and point-of-care diagnostics accelerates market growth opportunities.

Market Restraints:

Despite promising growth prospects, the digital PCR market faces challenges related to high instrument costs, complex assay development requirements, and regulatory complexities governing diagnostic tests. Variability in assay performance and the need for skilled personnel for data analysis pose additional barriers to market penetration, particularly in resource-limited settings. Addressing these challenges requires continuous innovation in assay design, cost-effective platform development, and strategic collaborations to streamline regulatory pathways.

Market Opportunities:

The digital PCR market presents significant growth opportunities driven by technological innovations, increasing healthcare expenditure, and rising patient demand for personalized diagnostic solutions. Integration of artificial intelligence and machine learning in digital PCR platforms enhances data analysis capabilities and improves diagnostic accuracy. Moreover, expanding applications in non-invasive prenatal testing, infectious disease monitoring, and cancer biomarker analysis broaden market prospects. Strategic partnerships, investment in research and development, and geographic expansion into emerging markets are crucial for capitalizing on evolving opportunities and sustaining competitive advantage.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the global digital PCR market?
  • Which applications and end-user segments are propelling adoption of digital PCR technologies?
  • How are technological advancements reshaping the competitive landscape of the digital PCR market?
  • Who are the key players contributing to the digital PCR market, and what strategies are they employing to maintain market leadership?
  • What are the emerging trends and future prospects in the global digital PCR market?

Competitive Intelligence and Business Strategy:

Leading players in the global digital PCR market, including major companies such as Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., and jn medsys, focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies invest significantly in R&D to develop next-generation digital PCR platforms, expand assay portfolios, and enhance automation capabilities. Collaborations with clinical laboratories, biopharmaceutical firms, and regulatory agencies facilitate market access and drive technology adoption. Moreover, emphasis on clinical validation studies, regulatory compliance, and customer education promotes market growth and enhances diagnostic accuracy in the rapidly evolving digital PCR landscape.

Key Companies Profiled:

  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific Inc.
  • Fluidigm Corp.
  • Formulatrix, Inc.
  • JN Medsys.
  • STILLA TECHNOLOGIES
  • Avance Bioscience
  • Fluidgm corporation,
  • jn medsys
  • Merck KGAA
  • Precigenome LLC
  • QIAGEN N.V
  • Sysmex corporation

Key Segments of the Digital PCR Industry

By Product:

  • Instrument
  • Consumables
  • Services

By End User:

  • Pharmaceutical Companies
  • Research Institutes
  • Forensic Labs
  • Agriculture Companies

By Application:

  • Clinical Diagnostics
  • Basic Research
  • Applied Research
  • Forensic Testing

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Technology Roadmap
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusion and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption Analysis
  • 4.2. New Product Launches and Approvals
  • 4.3. Regulatory Scenario
  • 4.4. Key Promotional Strategies by Manufacturers
  • 4.5. Recent Product Launches
  • 4.6. PESTEL Analysis
  • 4.7. Porter's Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Industry Outlook
    • 5.1.3. Global PCR Market Analysis
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Top Companies Historical Growth
    • 5.2.2. Technology Advancements in diagnostic imaging
    • 5.2.3. New Product Launches
    • 5.2.4. Growing Geriatric Population
    • 5.2.5. Increasing minimally invasive procedures
    • 5.2.6. Increased Funding and Support from the Government
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID19 Crisis Analysis

  • 6.1. 2024 Market Scenario
  • 6.2. COVID-19 and Impact Analysis
    • 6.2.1. By Product
    • 6.2.2. By End User
    • 6.2.3. By Application
    • 6.2.4. By Region

7. Global Digital PCR Market Demand (in Volume) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market (Volume) Analysis, 2019-2023
  • 7.2. Current and Future Market (Volume) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Digital PCR Market - Pricing Analysis

  • 8.1. Regional Pricing Analysis, By Product
  • 8.2. Global Average Pricing Analysis Benchmark
  • 8.3. Pricing Assumptions

9. Global Digital PCR Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

  • 9.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 9.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
    • 9.2.1. Y-o-Y Growth Trend Analysis
    • 9.2.2. Absolute $ Opportunity Analysis

10. Global Digital PCR Market Analysis 2019-2023 and Forecast 2024-2033, By Product

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis by Product, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2024-2033
    • 10.3.1. Instrument
    • 10.3.2. Consumables
    • 10.3.3. Services
  • 10.4. Market Attractiveness Analysis, By Product

11. Global Digital PCR Market Analysis 2019-2023 and Forecast 2024-2033, By Application

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) Analysis by Application, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2033
    • 11.3.1. Clinical Diagnostics
    • 11.3.2. Basic Research
    • 11.3.3. Applied Research
    • 11.3.4. Forensic Testing
  • 11.4. Market Attractiveness Analysis, By Application

12. Global Digital PCR Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2023
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2033
    • 12.3.1. Pharmaceutical Companies
    • 12.3.2. Research Institutes
    • 12.3.3. Forensic Labs
    • 12.3.4. Agriculture Companies
  • 12.4. Market Attractiveness Analysis, By End User

13. Global Digital PCR Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis by Region, 2019-2023
  • 13.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Region, 2024-2033
    • 13.3.1. North America
    • 13.3.2. Latin America
    • 13.3.3. Europe
    • 13.3.4. South Asia
    • 13.3.5. East Asia
    • 13.3.6. Oceania
    • 13.3.7. Middle East and Africa
  • 13.4. Market Attractiveness Analysis, By Region

14. North America Digital PCR Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. U.S.
      • 14.3.1.2. Canada
    • 14.3.2. By Product
    • 14.3.3. By End User
    • 14.3.4. By Application
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By End User
    • 14.4.4. By Application
  • 14.5. Key Market Participants - Intensity Mapping
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Key Market Trends
  • 14.8. Country-Level Analysis & Forecast
    • 14.8.1. U.S. Digital PCR Market
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Product
        • 14.8.1.2.2. By End User
        • 14.8.1.2.3. By Application
    • 14.8.2. Canada Digital PCR Market
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Product
        • 14.8.2.2.2. By End User
        • 14.8.2.2.3. By Application

15. Latin America Digital PCR Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. Mexico
      • 15.3.1.2. Brazil
      • 15.3.1.3. Argentina
      • 15.3.1.4. Rest of Latin America
    • 15.3.2. By Product
    • 15.3.3. By End User
    • 15.3.4. By Application
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By End User
    • 15.4.4. By Application
  • 15.5. Key Market Participants - Intensity Mapping
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Key Market Trends
  • 15.8. Country-Level Analysis & Forecast
    • 15.8.1. Mexico Digital PCR Market
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Product
        • 15.8.1.2.2. By End User
        • 15.8.1.2.3. By Application
    • 15.8.2. Brazil Surgical Imaging Market
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Product
        • 15.8.2.2.2. By End User
        • 15.8.2.2.3. By Application
    • 15.8.3. Argentina Digital PCR Market
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Product
        • 15.8.3.2.2. By End User
        • 15.8.3.2.3. By Application

16. Europe Digital PCR Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. U.K.
      • 16.3.1.2. Germany
      • 16.3.1.3. Italy
      • 16.3.1.4. France
      • 16.3.1.5. Spain
      • 16.3.1.6. Russia
      • 16.3.1.7. BENELUX
      • 16.3.1.8. Rest of Europe
    • 16.3.2. By Product
    • 16.3.3. By End User
    • 16.3.4. By Application
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By End User
    • 16.4.4. By Application
  • 16.5. Key Market Participants - Intensity Mapping
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Key Market Trends
  • 16.8. Country-Level Analysis & Forecast
    • 16.8.1. U.K. Digital PCR Market
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Product
        • 16.8.1.2.2. By End User
        • 16.8.1.2.3. By Application
    • 16.8.2. Germany Digital PCR Market
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Product
        • 16.8.2.2.2. By End User
        • 16.8.2.2.3. By Application
    • 16.8.3. Italy Digital PCR Market
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.3.2.1. By Product
        • 16.8.3.2.2. By End User
        • 16.8.3.2.3. By Application
    • 16.8.4. France Digital PCR Market
      • 16.8.4.1. Introduction
      • 16.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.4.2.1. By Product
        • 16.8.4.2.2. By End User
        • 16.8.4.2.3. By Application
    • 16.8.5. Spain Digital PCR Market
      • 16.8.5.1. Introduction
      • 16.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.5.2.1. By Product
        • 16.8.5.2.2. By End User
        • 16.8.5.2.3. By Application
    • 16.8.6. Russia Digital PCR Market
      • 16.8.6.1. Introduction
      • 16.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.6.2.1. By Product
        • 16.8.6.2.2. By End User
        • 16.8.6.2.3. By Application
    • 16.8.7. BENULUX Digital PCR Market
      • 16.8.7.1. Introduction
      • 16.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.7.2.1. By Product
        • 16.8.7.2.2. By End User
        • 16.8.7.2.3. By Application

17. South Asia Digital PCR Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. India
      • 17.3.1.2. Indonesia
      • 17.3.1.3. Malaysia
      • 17.3.1.4. Thailand
      • 17.3.1.5. Rest of South Asia
    • 17.3.2. By Product
    • 17.3.3. By End User
    • 17.3.4. By Application
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By End User
    • 17.4.4. By Application
  • 17.5. Key Market Participants - Intensity Mapping
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Key Market Trends
  • 17.8. Country-Level Analysis & Forecast
    • 17.8.1. India Digital PCR Market
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Product
        • 17.8.1.2.2. By End User
        • 17.8.1.2.3. By Application
    • 17.8.2. Indonesia Digital PCR Market
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Product
        • 17.8.2.2.2. By End User
        • 17.8.2.2.3. By Application
    • 17.8.3. Malaysia Digital PCR Market
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.3.2.1. By Product
        • 17.8.3.2.2. By End User
        • 17.8.3.2.3. By Application
    • 17.8.4. Thailand Digital PCR Market
      • 17.8.4.1. Introduction
      • 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.4.2.1. By Product
        • 17.8.4.2.2. By End User
        • 17.8.4.2.3. By Application

18. East Asia Digital PCR Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. China
      • 18.3.1.2. Japan
      • 18.3.1.3. South Korea
    • 18.3.2. By Product
    • 18.3.3. By End User
    • 18.3.4. By Application
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Product
    • 18.4.3. By End User
    • 18.4.4. By Application
  • 18.5. Key Market Participants - Intensity Mapping
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Key Market Trends
  • 18.8. Country Level Analysis & Forecast
    • 18.8.1. China Digital PCR Market
      • 18.8.1.1. Introduction
      • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.1.2.1. By Product
        • 18.8.1.2.2. By End User
        • 18.8.1.2.3. By Application
    • 18.8.2. Japan Digital PCR Market
      • 18.8.2.1. Introduction
      • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.2.2.1. By Product
        • 18.8.2.2.2. By End User
        • 18.8.2.2.3. By Application
    • 18.8.3. South Korea Digital PCR Market
      • 18.8.3.1. Introduction
      • 18.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.3.2.1. By Product
        • 18.8.3.2.2. By End User
        • 18.8.3.2.3. By Application

19. Oceania Digital PCR Market Analysis 2019-2023 and Forecast 2024-2033

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
    • 19.3.1. By Country
      • 19.3.1.1. Australia
      • 19.3.1.2. New Zealand
    • 19.3.2. By Product
    • 19.3.3. By End User
    • 19.3.4. By Application
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Product
    • 19.4.3. By End User
    • 19.4.4. By Application
  • 19.5. Key Market Participants - Intensity Mapping
  • 19.6. Drivers and Restraints - Impact Analysis
  • 19.7. Key Market Trends
  • 19.8. Country Level Analysis & Forecast
    • 19.8.1. Australia Digital PCR Market
      • 19.8.1.1. Introduction
      • 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.1.2.1. By Product
        • 19.8.1.2.2. By End User
        • 19.8.1.2.3. By Application
    • 19.8.2. New Zealand Digital PCR Market
      • 19.8.2.1. Introduction
      • 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.2.2.1. By Product
        • 19.8.2.2.2. By End User
        • 19.8.2.2.3. By Application

20. Middle East and Africa (MEA) Digital PCR Market Analysis 2019-2023 and Forecast 2024-2033

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
  • 20.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
    • 20.3.1. By Country
      • 20.3.1.1. GCC Countries
      • 20.3.1.2. Turkey
      • 20.3.1.3. South Africa
      • 20.3.1.4. Rest of Middle East and Africa
    • 20.3.2. By Product
    • 20.3.3. By End User
    • 20.3.4. By Application
  • 20.4. Market Attractiveness Analysis
    • 20.4.1. By Country
    • 20.4.2. By Product
    • 20.4.3. By End User
    • 20.4.4. By Application
  • 20.5. Key Market Participants - Intensity Mapping
  • 20.6. Drivers and Restraints - Impact Analysis
  • 20.7. Key Market Trends
  • 20.8. Country Level Analysis & Forecast
    • 20.8.1. GCC Countries Digital PCR Market
      • 20.8.1.1. Introduction
      • 20.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.1.2.1. By Product
        • 20.8.1.2.2. By End User
        • 20.8.1.2.3. By Application
    • 20.8.2. Turkey Digital PCR Market
      • 20.8.2.1. Introduction
      • 20.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.2.2.1. By Product
        • 20.8.2.2.2. By End User
        • 20.8.2.2.3. By Application
    • 20.8.3. South Africa Digital PCR Market
      • 20.8.3.1. Introduction
      • 20.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.3.2.1. By Product
        • 20.8.3.2.2. By End User
        • 20.8.3.2.3. By Application
    • 20.8.4. North Africa Digital PCR Market
      • 20.8.4.1. Introduction
      • 20.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.4.2.1. By Product
        • 20.8.4.2.2. By End User
        • 20.8.4.2.3. By Application

21. Market Structure Analysis

  • 21.1. Market Analysis by Tier of Companies
  • 21.2. Market Share Analysis of Top Players
  • 21.3. Market Presence Analysis
    • 21.3.1. Regional footprint of Players
    • 21.3.2. Product footprint by Players
    • 21.3.3. Channel footprint by Players

22. Competition Analysis

  • 22.1. Competition Dashboard
  • 22.2. Competition Benchmarking
  • 22.3. Competition Deep Dive
    • 22.3.1. Bio-Rad Laboratories, Inc.
      • 22.3.1.1. Company Overview
      • 22.3.1.2. Product Portfolio
      • 22.3.1.3. Sales Footprint
      • 22.3.1.4. Key Financials
      • 22.3.1.5. SWOT Analysis
      • 22.3.1.6. Key Developments
      • 22.3.1.7. Strategy Overview
        • 22.3.1.7.1. Marketing Strategy
        • 22.3.1.7.2. Product Strategy
        • 22.3.1.7.3. Channel Strategy
    • 22.3.2. Thermo Fisher Scientific Inc.
      • 22.3.2.1. Company Overview
      • 22.3.2.2. Product Portfolio
      • 22.3.2.3. Sales Footprint
      • 22.3.2.4. Key Financials
      • 22.3.2.5. SWOT Analysis
      • 22.3.2.6. Key Developments
      • 22.3.2.7. Strategy Overview
        • 22.3.2.7.1. Marketing Strategy
        • 22.3.2.7.2. Product Strategy
        • 22.3.2.7.3. Channel Strategy
    • 22.3.3. Fluidigm Corp.
      • 22.3.3.1. Company Overview
      • 22.3.3.2. Product Portfolio
      • 22.3.3.3. Sales Footprint
      • 22.3.3.4. Key Financials
      • 22.3.3.5. SWOT Analysis
      • 22.3.3.6. Key Developments
      • 22.3.3.7. Strategy Overview
        • 22.3.3.7.1. Marketing Strategy
        • 22.3.3.7.2. Product Strategy
        • 22.3.3.7.3. Channel Strategy
    • 22.3.4. Formulatrix, Inc.
      • 22.3.4.1. Company Overview
      • 22.3.4.2. Product Portfolio
      • 22.3.4.3. Sales Footprint
      • 22.3.4.4. Key Financials
      • 22.3.4.5. SWOT Analysis
      • 22.3.4.6. Key Developments
      • 22.3.4.7. Strategy Overview
        • 22.3.4.7.1. Marketing Strategy
        • 22.3.4.7.2. Product Strategy
        • 22.3.4.7.3. Channel Strategy
    • 22.3.5. JN Medsys.
      • 22.3.5.1. Company Overview
      • 22.3.5.2. Product Portfolio
      • 22.3.5.3. Sales Footprint
      • 22.3.5.4. Key Financials
      • 22.3.5.5. SWOT Analysis
      • 22.3.5.6. Key Developments
      • 22.3.5.7. Strategy Overview
        • 22.3.5.7.1. Marketing Strategy
        • 22.3.5.7.2. Product Strategy
        • 22.3.5.7.3. Channel Strategy
    • 22.3.6. STILLA TECHNOLOGIES
      • 22.3.6.1. Company Overview
      • 22.3.6.2. Product Portfolio
      • 22.3.6.3. Sales Footprint
      • 22.3.6.4. Key Financials
      • 22.3.6.5. SWOT Analysis
      • 22.3.6.6. Key Developments
      • 22.3.6.7. Strategy Overview
        • 22.3.6.7.1. Marketing Strategy
        • 22.3.6.7.2. Product Strategy
        • 22.3.6.7.3. Channel Strategy
    • 22.3.7. Avance Bioscience
      • 22.3.7.1. Company Overview
      • 22.3.7.2. Product Portfolio
      • 22.3.7.3. Sales Footprint
      • 22.3.7.4. Key Financials
      • 22.3.7.5. SWOT Analysis
      • 22.3.7.6. Key Developments
      • 22.3.7.7. Strategy Overview
        • 22.3.7.7.1. Marketing Strategy
        • 22.3.7.7.2. Product Strategy
        • 22.3.7.7.3. Channel Strategy
    • 22.3.8. Fluidgm corporation,
      • 22.3.8.1. Company Overview
      • 22.3.8.2. Product Portfolio
      • 22.3.8.3. Sales Footprint
      • 22.3.8.4. Key Financials
      • 22.3.8.5. SWOT Analysis
      • 22.3.8.6. Key Developments
      • 22.3.8.7. Strategy Overview
        • 22.3.8.7.1. Marketing Strategy
        • 22.3.8.7.2. Product Strategy
        • 22.3.8.7.3. Channel Strategy
    • 22.3.9. jn medsys
      • 22.3.9.1. Company Overview
      • 22.3.9.2. Product Portfolio
      • 22.3.9.3. Sales Footprint
      • 22.3.9.4. Key Financials
      • 22.3.9.5. SWOT Analysis
      • 22.3.9.6. Key Developments
      • 22.3.9.7. Strategy Overview
        • 22.3.9.7.1. Marketing Strategy
        • 22.3.9.7.2. Product Strategy
        • 22.3.9.7.3. Channel Strategy
    • 22.3.10. Merck KGAA
      • 22.3.10.1. Company Overview
      • 22.3.10.2. Product Portfolio
      • 22.3.10.3. Sales Footprint
      • 22.3.10.4. Key Financials
      • 22.3.10.5. SWOT Analysis
      • 22.3.10.6. Key Developments
      • 22.3.10.7. Strategy Overview
        • 22.3.10.7.1. Marketing Strategy
        • 22.3.10.7.2. Product Strategy
        • 22.3.10.7.3. Channel Strategy
    • 22.3.11. Precigenome LLC
      • 22.3.11.1. Company Overview
      • 22.3.11.2. Product Portfolio
      • 22.3.11.3. Sales Footprint
      • 22.3.11.4. Key Financials
      • 22.3.11.5. SWOT Analysis
      • 22.3.11.6. Key Developments
      • 22.3.11.7. Strategy Overview
        • 22.3.11.7.1. Marketing Strategy
        • 22.3.11.7.2. Product Strategy
        • 22.3.11.7.3. Channel Strategy
    • 22.3.12. QIAGEN N.V
      • 22.3.12.1. Company Overview
      • 22.3.12.2. Product Portfolio
      • 22.3.12.3. Sales Footprint
      • 22.3.12.4. Key Financials
      • 22.3.12.5. SWOT Analysis
      • 22.3.12.6. Key Developments
      • 22.3.12.7. Strategy Overview
        • 22.3.12.7.1. Marketing Strategy
        • 22.3.12.7.2. Product Strategy
        • 22.3.12.7.3. Channel Strategy
    • 22.3.13. Sysmex corporation.
      • 22.3.13.1. Company Overview
      • 22.3.13.2. Product Portfolio
      • 22.3.13.3. Sales Footprint
      • 22.3.13.4. Key Financials
      • 22.3.13.5. SWOT Analysis
      • 22.3.13.6. Key Developments
      • 22.3.13.7. Strategy Overview
        • 22.3.13.7.1. Marketing Strategy
        • 22.3.13.7.2. Product Strategy
        • 22.3.13.7.3. Channel Strategy

23. Assumptions and Acronyms Used

24. Research Methodology